Targeting histone deacetylases in idiopathic pulmonary fibrosis: a future therapeutic option
M Korfei, P Mahavadi, A Guenther - Cells, 2022 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited
therapeutic options, and there is a huge unmet need for new therapies. A growing body of …
therapeutic options, and there is a huge unmet need for new therapies. A growing body of …
[引用][C] Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option. Cells 2022, 11, 1626
M Korfei, P Mahavadi… - State of the Art …, 2022 - s Note: MDPI stays neutral with …